Karna Shinde invests in US-based cancer detection startup Navaux
Mumbai-based angel investor Karna D Shinde has invested significantly in Arkansas-based Navaux to develop a blood test aimed at enhancing early cancer detection and treatment monitoring. The investment will help Navaux to establish connections in the Indian healthcare industry as it prepares to introduce its solutions to the market. Navaux's ACTIVH test is a noninvasive, quick, and easy method that detects elevated Hepsin levels in tumors.
Want to receive such news items in your inbox? Click Here to sign up for a trial.